10-Q Filing

HEALTHTECH SOLUTIONS, INC./UT CIK: 1307624 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0001262463-22-000147`
Period End Date	20220930
Filing Date	20221123
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	hltt930202210q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 78 Cash Flow Statement 72 Stockholders Equity 31

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Cash	`CashAndCashEquivalentsAtCarryingValue`	$192.01K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$7.11K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$720.78K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	-	USD	Point-in-time
Inventory	`InventoryNet`	$198.53K	USD	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$211.95K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$138.00K	USD	Point-in-time
Loan receivable	`LoansReceivableHeldForSaleAmount`	-	USD	Point-in-time
Loan receivable	`LoansReceivableHeldForSaleAmount`	$168.00K	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$3.97K	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$1.33M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$313.10K	USD	Point-in-time
Investment in and advance to non-consolidated affiliate	`DueFromAffiliateNoncurrent`	$110.00K	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value per share	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Investment in and advance to non-consolidated affiliate	`DueFromAffiliateNoncurrent`	$110.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Fixed Assets acquired net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$93.33K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Fixed Assets acquired net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	-	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	69.97M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	69.97M	shares	Point-in-time
Intangible assets net of accumulated amortization	`FiniteLivedIntangibleAssetsNet`	$106.89K	USD	Point-in-time
Intangible assets net of accumulated amortization	`FiniteLivedIntangibleAssetsNet`	-	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	69.97M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	69.97M	shares	Point-in-time
Total Long Term Assets	`AssetsNoncurrent`	$110.00K	USD	Point-in-time
Total Long Term Assets	`AssetsNoncurrent`	$310.23K	USD	Point-in-time
Total Assets	`Assets`	$423.10K	USD	Point-in-time
Total Assets	`Assets`	$1.64M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.98M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$733.74K	USD	Point-in-time
Loans from non-affiliated parties	`DueToRelatedPartiesCurrent`	-	USD	Point-in-time
Loans from non-affiliated parties	`DueToRelatedPartiesCurrent`	$1.15M	USD	Point-in-time
Loans from shareholders	`LoansFromShareholders`	$336.92K	USD	Point-in-time
Loans from shareholders	`LoansFromShareholders`	$1.36M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$4.49M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.07M	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.07M	USD	Point-in-time
Total Liabilities	`Liabilities`	$4.49M	USD	Point-in-time
Series A preferred stock, $0.001 par value, 2,000,000 authorized, 110,520 and 156,837 issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	`PreferredStockValue`	$110.00	USD	Point-in-time
Series A preferred stock, $0.001 par value, 2,000,000 authorized, 110,520 and 156,837 issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	`PreferredStockValue`	$110.00	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized, 69,965,933 issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$69.97K	USD	Point-in-time
Common stock, $0.001 par value, 200,000,000 shares authorized, 69,965,933 issued and outstanding as of September 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$66.97K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$10.25M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$9.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-10.55M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-12.66M	USD	Point-in-time
Stockholders' Equity (Deficit) Attributable to the Company:	`StockholdersEquity`	$-2.34M	USD	Point-in-time
Stockholders' Equity (Deficit) Attributable to the Company:	`StockholdersEquity`	$-647.56K	USD	Point-in-time
Non controlling Interest	`MinorityInterest`	-	USD	Point-in-time
Non controlling Interest	`MinorityInterest`	$-511.39K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-12.46K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.19M	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-851.91K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-647.56K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.43M	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.45M	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-562.60K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.85M	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$1.64M	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$423.10K	USD	Point-in-time

Income Statement 78 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	3 Qtrs
Revenue	`Revenues`	$776.22K	USD	3 Qtrs
Revenue	`Revenues`	$776.22K	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Cost of Goods	`CostOfRevenue`	-	USD	1 Quarter
Cost of Goods	`CostOfRevenue`	$51.83K	USD	1 Quarter
Cost of Goods	`CostOfRevenue`	$51.83K	USD	3 Qtrs
Cost of Goods	`CostOfRevenue`	-	USD	3 Qtrs
Gross Profit	`GrossProfit`	$724.39K	USD	1 Quarter
Gross Profit	`GrossProfit`	$724.39K	USD	3 Qtrs
Gross Profit	`GrossProfit`	-	USD	1 Quarter
Gross Profit	`GrossProfit`	-	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$938.05K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.67M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.87M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.03M	USD	1 Quarter
General and administrative-related party	`GeneralAndAdministrativerelatedParty`	$92.50K	USD	1 Quarter
General and administrative-related party	`GeneralAndAdministrativerelatedParty`	$426.05K	USD	3 Qtrs
General and administrative-related party	`GeneralAndAdministrativerelatedParty`	$172.50K	USD	3 Qtrs
General and administrative-related party	`GeneralAndAdministrativerelatedParty`	$82.50K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$346.86K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$415.95K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$150.13K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.39M	USD	3 Qtrs
Research and development related party	`ResearchAndDevelopmentRelatedParty`	$18.00K	USD	1 Quarter
Research and development related party	`ResearchAndDevelopmentRelatedParty`	$54.00K	USD	3 Qtrs
Research and development related party	`ResearchAndDevelopmentRelatedParty`	$18.00K	USD	1 Quarter
Research and development related party	`ResearchAndDevelopmentRelatedParty`	$304.00K	USD	3 Qtrs
Depreciation & Amortization	`DepreciationAndAmortization`	$25.93K	USD	3 Qtrs
Depreciation & Amortization	`DepreciationAndAmortization`	$6.48K	USD	1 Quarter
Depreciation & Amortization	`DepreciationAndAmortization`	$21.45K	USD	1 Quarter
Depreciation & Amortization	`DepreciationAndAmortization`	$57.21K	USD	3 Qtrs
Total Operating Expenses	`OperatingExpenses`	$2.97M	USD	3 Qtrs
Total Operating Expenses	`OperatingExpenses`	$3.35M	USD	3 Qtrs
Total Operating Expenses	`OperatingExpenses`	$1.57M	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$1.21M	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-844.92K	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-1.21M	USD	1 Quarter
Loss from Operations	`OperatingIncomeLoss`	$-2.63M	USD	3 Qtrs
Loss from Operations	`OperatingIncomeLoss`	$-2.97M	USD	3 Qtrs
Interest expense	`InterestExpense`	-	USD	3 Qtrs
Interest expense	`InterestExpense`	$367.14K	USD	3 Qtrs
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest expense	`InterestExpense`	-	USD	1 Quarter
Change in fair value of derivative liabilities	`GainLossOnSaleOfDerivatives`	-	USD	1 Quarter
Change in fair value of derivative liabilities	`GainLossOnSaleOfDerivatives`	$-2.93M	USD	3 Qtrs
Change in fair value of derivative liabilities	`GainLossOnSaleOfDerivatives`	-	USD	1 Quarter
Change in fair value of derivative liabilities	`GainLossOnSaleOfDerivatives`	-	USD	3 Qtrs
Total Other Expenses	`NonoperatingIncomeExpense`	-	USD	1 Quarter
Total Other Expenses	`NonoperatingIncomeExpense`	$-3.30M	USD	3 Qtrs
Total Other Expenses	`NonoperatingIncomeExpense`	-	USD	1 Quarter
Total Other Expenses	`NonoperatingIncomeExpense`	-	USD	3 Qtrs
Loss before provision for income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.21M	USD	1 Quarter
Loss before provision for income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-6.27M	USD	3 Qtrs
Loss before provision for income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-844.92K	USD	1 Quarter
Loss before provision for income tax	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-2.63M	USD	3 Qtrs
Provision for income tax	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Provision for income tax	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Net Loss	`ProfitLoss`	$-844.92K	USD	1 Quarter
Net Loss	`ProfitLoss`	$-2.63M	USD	3 Qtrs
Net Loss	`ProfitLoss`	$-6.27M	USD	3 Qtrs
Net Loss	`ProfitLoss`	$-1.21M	USD	1 Quarter
Net loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-448.47K	USD	3 Qtrs
Net loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-108.85K	USD	1 Quarter
Net loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-3.40K	USD	1 Quarter
Net loss attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-4.61K	USD	3 Qtrs
Net Loss attributable to Controlling Interest	`NetIncomeLoss`	$-1.20M	USD	1 Quarter
Net Loss attributable to Controlling Interest	`NetIncomeLoss`	$-2.18M	USD	3 Qtrs
Net Loss attributable to Controlling Interest	`NetIncomeLoss`	$-736.08K	USD	1 Quarter
Net Loss attributable to Controlling Interest	`NetIncomeLoss`	$-6.27M	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$-0.01	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.04	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$-0.31	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$-0.04	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	19.93M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	67.09M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	67.33M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	29.15M	shares	1 Quarter

Cash Flow Statement 72 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLossAllocatedToGeneralPartners`	$-2.63M	USD	3 Qtrs
Net loss	`NetIncomeLossAllocatedToGeneralPartners`	$-6.27M	USD	3 Qtrs
Amortization expense	`AmortizationOfIntangibleAssets`	$25.93K	USD	3 Qtrs
Amortization expense	`AmortizationOfIntangibleAssets`	$30.54K	USD	3 Qtrs
Depreciation expense	`DepreciationDepletionAndAmortization`	$26.67K	USD	3 Qtrs
Amortization of discount on convertible debenture	`AmortizationOfDebtDiscountPremium`	-	USD	3 Qtrs
Amortization of discount on convertible debenture	`AmortizationOfDebtDiscountPremium`	$351.21K	USD	3 Qtrs
Non-cash compensation	`NoncashCompensation`	$100.00K	USD	3 Qtrs
Non-cash stock option expense	`StockOptionPlanExpense`	$135.00K	USD	3 Qtrs
Stock compensation expense	`ShareBasedCompensation`	$1.03M	USD	3 Qtrs
Stock compensation expense	`ShareBasedCompensation`	-	USD	3 Qtrs
Inventory reserve	`InventoryWriteDown`	-	USD	3 Qtrs
Inventory reserve	`InventoryWriteDown`	$22.18K	USD	3 Qtrs
Allowance for bad debt	`ProvisionForDoubtfulAccounts`	-	USD	3 Qtrs
Allowance for bad debt	`ProvisionForDoubtfulAccounts`	$55.44K	USD	3 Qtrs
Non-cash interest expense	`OtherNoncashIncomeExpense`	-	USD	3 Qtrs
Non-cash interest expense	`OtherNoncashIncomeExpense`	$-15.87K	USD	3 Qtrs
Change in fair value of derivative liabilities	`UnrealizedGainLossOnDerivatives`	-	USD	3 Qtrs
Change in fair value of derivative liabilities	`UnrealizedGainLossOnDerivatives`	$-2.93M	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-103.26K	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$71.46K	USD	3 Qtrs
Prepaid commissions	`IncreaseDecreaseInPrepaidCommissions`	$266.64K	USD	3 Qtrs
Prepaid commissions	`IncreaseDecreaseInPrepaidCommissions`	-	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	-	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$220.71K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$776.22K	USD	3 Qtrs
Other payable	`IncreaseDecreaseInOtherAccountsPayable`	$-3.97K	USD	3 Qtrs
Other payable	`IncreaseDecreaseInOtherAccountsPayable`	-	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.43M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$419.23K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.57M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.99M	USD	3 Qtrs
Cash paid for purchase of Varian, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Cash paid for purchase of Varian, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$437.06K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-437.06K	USD	3 Qtrs
Proceeds of loans from shareholders	`ProceedsOfLoansFromShareholders`	$1.02M	USD	3 Qtrs
Proceeds of loans from shareholders	`ProceedsOfLoansFromShareholders`	$121.08K	USD	3 Qtrs
Proceeds from convertible debenture	`ProceedsFromConvertibleDebt`	-	USD	3 Qtrs
Proceeds from convertible debenture	`ProceedsFromConvertibleDebt`	$50.00K	USD	3 Qtrs
Settlement of loan from shareholder	`SettlementOfLoanFromShareholder`	$50.54K	USD	3 Qtrs
Settlement of loan from shareholder	`SettlementOfLoanFromShareholder`	-	USD	3 Qtrs
Loans from non-affiliated parties	`ProceedsFromRelatedPartyDebt`	$1.15M	USD	3 Qtrs
Loans from non-affiliated parties	`ProceedsFromRelatedPartyDebt`	-	USD	3 Qtrs
Capital contributions	`ProceedsFromContributionsFromParent`	$4.56K	USD	3 Qtrs
Capital contributions	`ProceedsFromContributionsFromParent`	-	USD	1 Quarter
Capital contributions	`ProceedsFromContributionsFromParent`	-	USD	3 Qtrs
Capital contributions	`ProceedsFromContributionsFromParent`	-	USD	1 Quarter
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.79M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.17M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.92M	USD	3 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$184.90K	USD	3 Qtrs
Net increase (decrease) in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-90.04K	USD	3 Qtrs
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$129.00K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.11K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$192.01K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$38.96K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$129.00K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$7.11K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$192.01K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$38.96K	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$61.00	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	-	USD	3 Qtrs
Cash paid for taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Cash paid for taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Acquired noncontrolling interest in business acquisition	`AcquiredNoncontrollingInterestInBusinessAcquisition`	-	USD	3 Qtrs
Acquired noncontrolling interest in business acquisition	`AcquiredNoncontrollingInterestInBusinessAcquisition`	$9.68K	USD	3 Qtrs
Acquisition of noncontrolling interest for issuance of common stock	`AcquiredNoncontrollingInterestForIssuanceOfCommonStock`	-	USD	3 Qtrs
Acquisition of noncontrolling interest for issuance of common stock	`AcquiredNoncontrollingInterestForIssuanceOfCommonStock`	$187.50K	USD	3 Qtrs
Issuance of Series C preferred shares related to business acquisition	`IssuanceOfSeriesCPreferredSharesRelatedToBusinessAcquisition`	-	USD	3 Qtrs
Issuance of Series C preferred shares related to business acquisition	`IssuanceOfSeriesCPreferredSharesRelatedToBusinessAcquisition`	$1.09M	USD	3 Qtrs

Stockholders Equity 31 line items

Line Item	Tag	Value	Unit	Period
Balance at June 30, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-12.46K	USD	Point-in-time
Balance at June 30, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.19M	USD	Point-in-time
Balance at June 30, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-851.91K	USD	Point-in-time
Balance at June 30, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-647.56K	USD	Point-in-time
Balance at June 30, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.43M	USD	Point-in-time
Balance at June 30, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.45M	USD	Point-in-time
Balance at June 30, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-562.60K	USD	Point-in-time
Balance at June 30, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.85M	USD	Point-in-time
Issuance of common stock for services	`StockIssuedDuringPeriodValueIssuedForServices`	$100.00K	USD	1 Quarter
Issuance of common stock for non-controlling interest	`IssuanceOfCommonStockForNoncontrollingInterest`	$187.50K	USD	1 Quarter
Issuance of stock options	`ProceedsFromStockOptionsExercised`	$135.00K	USD	1 Quarter
Issuance of common stock	`StockIssuedDuringPeriodValueNewIssues`	$2.82M	USD	1 Quarter
Issuance of Series C Preferred for acquisition of Varian	`IssuanceOfSeriesCPreferredForAcquisitionOfVarian`	$-9.67K	USD	1 Quarter
Non controlling interest associated with acquisition of Varian	`NonControllingInterestAssociatedWithAcquisitionOfVarian`	$9.68K	USD	1 Quarter
Conversion of Series A Preferred into common stock	`ConversionOfSeriesPreferredIntoCommonStock`	-	USD	1 Quarter
Conversion of Debentures into common stock	`ConversionOfDebenturesIntoCommonStock`	$4.00M	USD	1 Quarter
Capital contributions	`AdjustmentsToAdditionalPaidInCapitalOther`	$4.56K	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-4.78M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.21M	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-293.88K	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-979.80K	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-801.35K	USD	1 Quarter
Net loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-844.92K	USD	1 Quarter
Balance at September 30, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-12.46K	USD	Point-in-time
Balance at September 30, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.19M	USD	Point-in-time
Balance at September 30, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-851.91K	USD	Point-in-time
Balance at September 30, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-647.56K	USD	Point-in-time
Balance at September 30, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.43M	USD	Point-in-time
Balance at September 30, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.45M	USD	Point-in-time
Balance at September 30, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-562.60K	USD	Point-in-time
Balance at September 30, 2022	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.85M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.